Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), ArriVent BioPharma, Inc. (AVBP) and Evommune, Inc. (EVMN)
at www.tipranks.com (Fri, 6-Mar 7:40 AM)
CATX Raises $175 Million to Accelerate Cancer Treatment Pipeline—What Does This Capital Infusion Signal?
Market Chameleon (Tue, 3-Feb 11:09 AM)
CATX's $175 Million Stock and Warrant Offering Secures Major Institutional Support—What Does It Mean for Investors?
Market Chameleon (Mon, 2-Feb 11:07 AM)
